Vertigo relief app

📊 Full opportunity report: Vertigo relief app on IdeaNavigator AI — validation score, market gap, and execution plan.

TL;DR

A proposed vertigo relief app is being developed to help adults manage BPPV at home using guided maneuvers and motion sensors. It targets patients and clinics, with testing underway for validation and adoption.

A new vertigo relief app is in development to assist adults suffering from benign paroxysmal positional vertigo (BPPV) in self-administering repositioning maneuvers at home. The app aims to address the long wait times for specialist care and improve self-treatment accuracy, with testing phases beginning soon. This approach is similar to the unbundling of personal finance apps that is transforming digital therapeutics. This initiative could transform home-based vestibular care and expand digital therapeutics in the field.

The proposed vertigo relief app targets adults, primarily women and older individuals, experiencing recurrent BPPV, the most common vestibular disorder. It is designed to guide users through maneuvers like the Epley and Brandt-Daroff with animated instructions, audio cues, and real-time gyroscope feedback to ensure proper head positioning. The app will also log dizziness episodes, triggers, and symptom severity, providing a comprehensive symptom tracking tool.

Developers plan to launch a minimum viable product (MVP) on both iOS and Android platforms, potentially integrating features from question-answering apps to enhance user guidance. The MVP will include a screening tool for BPPV candidacy, guided maneuver instructions, and symptom logging, accompanied by a clear disclaimer stating it is not a substitute for medical advice. The app will be offered as a freemium service for consumers, with paid tiers offering advanced features such as history export and reminders. For clinics and healthcare providers, licensing options could be explored, similar to guest apps with scheduling features. Additionally, clinics and healthcare providers could license the app for patient use between visits, integrating it into existing vestibular care workflows.

Potential Impact on Vestibular Care and Patient Self-Management

This vertigo relief app has the potential to significantly improve self-treatment accuracy for BPPV patients, reducing relapse rates and enabling more immediate symptom management. For clinics and ENT practices, it offers a scalable way to support patients remotely, especially as telehealth and home-based rehab become more prevalent. The market for digital vestibular therapeutics is growing, with estimates near USD 498 million in 2024 and a projected annual growth rate of around 13.5%, indicating strong industry acceptance.

By providing guided, sensor-assisted maneuvers, the app could reduce the reliance on static diagrams and improve patient outcomes, especially in underserved areas with long wait times for specialist care. Its success could pave the way for broader adoption of digital tools in vestibular disorder management, aligning with trends accelerated by COVID-19 towards telehealth solutions.

Background on BPPV and Digital Therapeutics Development

BPPV is the most common vestibular disorder, characterized by brief episodes of vertigo triggered by head movements. It often requires repositioning maneuvers like the Epley to resolve symptoms, but many patients struggle to perform these correctly at home due to lack of guidance and feedback. Traditionally, treatment involves visits to ENT or vestibular specialists, with relapse rates around 50%.

The rise of telehealth and digital therapeutics has prompted development of remote management tools. The market for digital vestibular rehab platforms was estimated at nearly USD 498 million in 2024, with increasing acceptance among providers and payers. Smartphones now include accurate motion sensors capable of measuring head angles, enabling real-time feedback during self-administered maneuvers.

“The app aims to bridge the gap between clinic visits by providing guided, sensor-supported maneuvers for patients at home.”

— an anonymous researcher

Uncertainties Around Clinical Validation and Adoption

It is not yet clear how effective the app will be in real-world settings, or how quickly clinics and patients will adopt it. Validation studies are still in planning or early testing phases, and regulatory or reimbursement pathways remain to be fully clarified.

Next Steps for Testing and Market Entry

Developers plan to launch a landing page with a guided Epley walkthrough and run targeted ads to measure user engagement and symptom tracking. Simultaneously, they will pitch clinics and ENT practices to adopt the app for patient home care, aiming to gather feedback and establish clinical partnerships. Further validation studies and regulatory assessments are expected in the coming months.

Key Questions

How does the vertigo relief app work?

The app guides users through repositioning maneuvers like the Epley, using animations, audio cues, and gyroscope-based head-angle feedback to ensure correct execution. It also logs symptoms and episodes for tracking over time.

Is the app a substitute for seeing a doctor?

No. The app includes a disclaimer stating it is not a substitute for professional medical advice and encourages users to consult a healthcare provider if symptoms worsen or red-flag signs appear.

Who can benefit from this app?

Adults experiencing recurrent BPPV, especially those who face long wait times for specialist care or prefer managing symptoms at home, are the primary target users.

When will the app be available for public use?

Deployment depends on validation and pilot testing results. Developers plan to conduct initial testing soon, with a potential public release following successful validation and regulatory review.

How will clinics use the app?

ENT, audiology, and vestibular physiotherapy practices can license the app to recommend to patients for between-visit home management, integrating it into their treatment protocols.

Source: IdeaNavigator AI